Roll-up of 3 projects. Projects are the summable leaves — the PE total is their sum, never added to it.
For fiscal year 2027, Defense-Wide agencies are requesting $364.1M for Warfighting Performance under RDT&E program element 0602024E, up 18% over FY2026.
Funding profile, FY2025–FY2031
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure.
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 0.0 |
| FY2026 | Enacted | 307.7 |
| FY2027 | Request | 364.1 |
| FY2028 | Outyear | 381.4 |
| FY2029 | Outyear | 407.1 |
| FY2030 | Outyear | 412.9 |
| FY2031 | Outyear | 419.2 |
Acquisition lifecycle
This program is funded in RDT&E Budget Activity 2 — Applied Research.
3 projects roll up into PE 0602024E
Projects are the summable leaves — the PE total is their sum, never added to it. Program elements and projects carry the full five-year plan; activities stop at the budget year. This PE moves 18% overall, which can hide much larger swings below.
BIOLOGICALLY BASED MATERIALS AND DEVICES
WARFIGHTING PERFORMANCE SUPPORT
Congressional marks
Committee marks on the FY2027 request. Adds and cuts are reconciled in conference before they become law.
Mission & acquisition strategy
The efforts described in this Program Element (PE) address the Applied Research associated with the Warfighting Performance program that is focused on developing biologically based materials and biological technologies that make possible a wide range of new military capabilities. This PE also supports innovation and robust transition planning in the technology cycle by working with entrepreneurs to increase the likelihood that DARPA funded technologies take root in the U.S. and provide new capabilities for national defense.
Ask this program element
Answers are generated from the figures on this page — the FY2027 justification exhibits and the marks tracked above — and nothing else is consulted. Confirm any figure against the cited exhibit before you use it externally.
This page carries the budget justification and the NDAA marks — nothing else. For what a contractor has actually been obligated, the ledger is at hitchintel.com/vendors; for live solicitations, hitchintel.com/opportunities. Both are member surfaces.
Cite this page
/programs/0602024E.md · MCP mcp.hitchintel.com → budget_get_program_element, budget_get_cong_marksBIOMEDICAL TECHNOLOGY — one RDT&E project inside PE 0602024E. Congressional marks are recorded on the program element, not on a project.
Project WP-02 — BIOMEDICAL TECHNOLOGY — requests $190.0M in FY2027, 52% of the $364.1M requested for program element 0602024E. Year over year it grows 14% against FY2026.
Project WP-02 funding, FY2025–FY2031
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure. Projects carry the full five-year plan; the activities inside them stop at the budget year.
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 0.0 |
| FY2026 | Enacted | 166.5 |
| FY2027 | Request | 190.0 |
| FY2028 | Outyear | 202.6 |
| FY2029 | Outyear | 205.8 |
| FY2030 | Outyear | 208.4 |
| FY2031 | Outyear | 211.4 |
14 accomplishments / planned programs
The R-2A exhibit. Activities carry the prior, current and budget year only — no five-year plan — and they are descriptive: coverage is partial and they do not always add back to the project, so count them, never total them. Opening lines only here — the full year-by-year narrative is on the project page.
- Demonstrate accuracy in identifying single and mixed groups of microorganisms in vitro. - Demonstrate efficacy for at least one novel wound infection treatment approach in vitro. - Determine the appropriate regulatory pathway(s) for the wound infection sensing and treatment devices with the Food and Drug Administration. - Finalize the…
Read the FY2027 plan →- Demonstrate delivery of countermeasure cargo in additional cell types. - Demonstrate systemic delivery of countermeasure cargo. - Develop and demonstrate scale-up manufacturing of the highest-performing delivery vehicles. - Demonstrate delivery of two or more MCM modalities.
Read the FY2027 plan →- Refine NIR light delivery parameters to improve activation of candidate molecules. - Design and initiate safety and efficacy studies to support an Investigational New Drug (IND) submission to the U.S. Food and Drug Administration. - Characterize the effect of NIR light-activated candidate molecule(s) on cognitive performance following…
- Conduct trials to validate system performance and refine interventions for optimal effectiveness. - Assess gaps in system readiness and outline steps for military integration and deployment.
- Demonstrate successful end-to-end computational design, nomination, and validation of inhibitor candidates. - Demonstrate a novel inhibitor discovery pipeline. - Develop, demonstrate, and deliver a complete technology transfer package.
- Evaluate the physiological changes and immunological effects of modified RBCs based on cargo parameters. - Validate RBC modification and determine if the approach can be scaled. - Assess the impact of the RBC-modified cargos and device platforms on RBCs.
- Demonstrate the usefulness of care technologies that directly integrate oxygen and hemorrhage support during polytrauma (i.e., injury conditions requiring both types of support). - Develop a proof-of-concept hardware feasibility assessment illustrating how oxygen and hemorrhage support hardware could be combined into a portable form…
- Generate molecular components that respond to distinct wavelengths of light. - Generate molecular components capable of producing nucleic acid sequences in response to light. - Initiate the development of a mechanism capable of detecting errors in a nucleotide sequence. - Initiate the integration of the developed components to generate…
Read the FY2027 plan →- Assess mechanisms to achieve localization of a bleed in animal models. - Develop systems capable of autonomous identification and navigation in desired form factors. - Demonstrate successful navigation of a sensor suite and end effector to key anatomical regions in animal models. - Demonstrate performance of context-aware bleed…
Read the FY2027 plan →- Predict binding sites within a protein dynamic trajectory. - Identify differences in protein dynamics between functional and dysfunctional protein targets that are relevant to chemical threat mechanisms. - Determine the structure and behavior of uncommon protein states. - Identify and validate energetically linked sites on the protein.
Read the FY2027 plan →- Continue studies on editing cells to produce, position, and retain novel proteins in mature RBCs. - Continue computer simulation of gene editing impact on RBC metabolism and virtually optimize protein position/retention on mature RBCs. - Initiate experiments to produce, position, and retain novel proteins in mature RBCs. - Identify any…
Read the FY2027 plan →- Initiate development of biological, bio-inspired, or bio-hybrid platforms that enhance the detection, characterization, and protection against emerging threats, both in warfighters and agricultural crops. - Investigate cellular engineering approaches that maintain physiology and viability and do not result in immunotoxicity…
Read the FY2027 plan →- Conduct a second large-scale field experimentation, integrating additional autonomy and operating challenges in a competition format. - Finalize a database of trauma signatures with additional novel cases, incorporating sensors developed in previous years. - Evaluate field-portable triage solutions with increased operational…
- Complete efficacy and safety studies with optimized therapeutic formulation against hemorrhage in complex trauma using animal models. - Provide the initial proof of concept for easy reconstitution and packaging suitability. - Provide the final demonstration of scaled-up manufacturing. - Complete final stability tests to demonstrate…
What project WP-02 buys
The Biomedical Technology project focuses on applied research for medical related technologies that will maintain warfighter health and performance before, during, or after operations. Successful technologies within this project will maintain warfighter health against emerging threats through novel biothreat detection, rapid medical countermeasure identification and development, and distributed production of effective therapeutics. In-theater, warfighter health will be maintained through the development of field-relevant technologies such as reliable and accessible critical medical resources, novel detection and protection capabilities for traumatic brain injury, and rapid, effective triage of battlefield injuries. Additionally, this project will improve warfighter readiness by characterizing and assaying physical and cognitive performance to drive data-driven awareness. Prior to FY 2026, efforts in this Project were funded in PE 0602115E, Project BT-01.
BIOLOGICALLY BASED MATERIALS AND DEVICES — one RDT&E project inside PE 0602024E. Congressional marks are recorded on the program element, not on a project.
Project WP-01 — BIOLOGICALLY BASED MATERIALS AND DEVICES — requests $147.0M in FY2027, 40% of the $364.1M requested for program element 0602024E. Year over year it grows 17% against FY2026.
Project WP-01 funding, FY2025–FY2031
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure. Projects carry the full five-year plan; the activities inside them stop at the budget year.
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 0.0 |
| FY2026 | Enacted | 125.7 |
| FY2027 | Request | 147.0 |
| FY2028 | Outyear | 142.8 |
| FY2029 | Outyear | 164.5 |
| FY2030 | Outyear | 166.7 |
| FY2031 | Outyear | 170.1 |
12 accomplishments / planned programs
The R-2A exhibit. Activities carry the prior, current and budget year only — no five-year plan — and they are descriptive: coverage is partial and they do not always add back to the project, so count them, never total them. Opening lines only here — the full year-by-year narrative is on the project page.
- Expand biology-based switching to include multiple pathways for consuming different feedstocks or producing different chemicals. - Extend the stability of biological systems for continuous production. - Implement approaches for switchable production in an industrially-relevant biomanufacturing system.
Read the FY2027 plan →- Complete long term plant growth and stabilization for selected species to support scaling approach. - Complete chemical exposure experiments to identify biochemical, molecular, and physiological patterns associated with exposure of plants to target stressors. - Evaluate plant exposure using multi-omics and external observable…
Read the FY2027 plan →- Increase power generation from conversion of organic matter compared to initial brassboard systems. - Validate that final brassboard systems can perform in stakeholder domains.
- Conduct large-scale validation studies of optimized Cognitive Flexibility and Emotional Regulation interventions across diverse warfighter populations to establish deployment readiness.
- Perform operationally relevant field testing of selected test materials. - Conduct post-field-testing laboratory analysis to characterize performance for key stakeholder use cases.
- Down-select technologies for continued development based on test results and demonstrator performance.
- Optimize technology development for use against the Brown Tree Snake. - Identify novel cell culture techniques to significantly enhance gene editing technology development in vertebrates. - Test effectiveness of vertebrate gene editing tools in laboratory trials. - Test effectiveness of gene editing technology in field trials for the…
Read the FY2027 plan →- Demonstrate model-driven, rational design of biological candidates and increase strength and selectivity of metal/mineral interactions. - Evaluate top biological metal/mineral processing candidates under real-world processing workflows and conditions. - Perform process durability assessments. - Refine the list of candidate biological…
Read the FY2027 plan →- Investigate approaches for the development of chemical and biological processes and biologically derived materials to support and sustain the warfighter in all conditions. - Initiate formulation and characterization of materials chemistries for the catalytic separation of domestic agricultural and forestry residues at the laboratory…
Read the FY2027 plan →- Initiate technology development for the integration of dynamic and responsive biological organisms or bio-inspired molecules into composite materials. - Investigate approaches for the development of biological processes and biologically derived materials to support and sustain the warfighter in austere conditions. - Explore methods…
Read the FY2027 plan →- Validate that models can predict microbial communities and/or fiber-based approaches after two months. - Identify microbial communities and/or fiber-based approaches that produce and maintain a desired function in the field. - Verify microbial communities and/or fiber-based approaches are either resistant or resilient to multiple…
- Demonstrate separation and efficient recovery of at least eight individual REEs with high purity starting from mining partner source material using a biomining approach.
What project WP-01 buys
The Biologically Based Materials and Devices project will leverage the growing application space of the biological sciences for the development of new DoW capabilities to improve the sustainability of warfighters and operational platforms in varied domains. This project will develop solutions for critical resource processing, materials development, threat detection and characterization, and warfighter resilience to infectious disease. The materials and technologies developed through this project will protect and sustain warfighters and operations in austere conditions, enhancing warfighter resiliency and lethality. Prior to FY 2026, efforts in this Project were funded in PE 0602715E, Project MBT-02.
WARFIGHTING PERFORMANCE SUPPORT — one RDT&E project inside PE 0602024E. Congressional marks are recorded on the program element, not on a project.
Project WP-07 — WARFIGHTING PERFORMANCE SUPPORT — requests $27.1M in FY2027, 7.5% of the $364.1M requested for program element 0602024E. Year over year it grows 75% against FY2026.
Project WP-07 funding, FY2025–FY2031
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure. Projects carry the full five-year plan; the activities inside them stop at the budget year.
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 0.0 |
| FY2026 | Enacted | 15.5 |
| FY2027 | Request | 27.1 |
| FY2028 | Outyear | 36.1 |
| FY2029 | Outyear | 36.8 |
| FY2030 | Outyear | 37.8 |
| FY2031 | Outyear | 37.8 |
What project WP-07 buys
The Warfighting Performance Support project contains management costs in support of DARPA functions and activities across the entire Warfighting Performance PE. These costs include: DARPA classified and unclassified network support and equipment; contractor support; classified program security; building security; commercial transition services that increase the likelihood that DARPA-funded technologies remain in the U.S. and provide new capabilities for national defense; DARPA outreach to universities and industry; external contracting, financial and support fees; Program Manager Intragovernmental Personnel Act (IPA) Funding; Program Managers from other Government Agencies; and similar operating expenses. Agency support is allocated on a pro-rata basis across the Agency's BA1, BA2 and BA3 PEs and, therefore, fluctuates per PE by fiscal year based on the total Agency budget in that fiscal year. Prior to FY 2026, support requirements in this Project were funded in PE 0602715E, Project MBT-02, and PE 0602115E, Project BT-01.